Position in BNTC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,345,000
+$948,750 QoQ
Shares Held
250,000
+11.1% QoQ
Ownership
0.728%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#18
of 87 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MYDA Advisors LLC holds $47,243,871 across 14 Biotechnology names. BNTC ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
1,150,000 | $17,112,000 | |
| 2 | MANE |
Veradermics, Inc
|
100,000 | $12,294,000 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
240,000 | $6,292,800 | |
| 4 | EYPT |
EyePoint, Inc.
|
250,000 | $3,575,000 | |
| 5 | BNTC |
Benitec Biopharma Inc.
This page
|
250,000 | $3,345,000 | |
| 6 | PROK |
Prokidney Corp.
|
640,775 | $1,307,181 | |
| 7 | IMTX |
Immatics N.V.
|
120,000 | $1,215,600 | |
| 8 | INSM |
INSMED Inc
|
7,000 | $746,340 |
All Filings in BNTC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,345,000 | 250,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,396,250 | 225,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,030,750 | 225,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $982,100 | 70,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $726,757 | 62,116 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $676,520 | 52,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $631,500 | 50,000 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||